Article information
Full text is only aviable in PDF
REFERENCES
[1]
Grupo Cooperativo Médico-Quirúrgico del Carcinoma Bronocogénico del Hospital Universitario 12 de Octubre.
Carcinoma broncogénico: algoritmo diagnóstico-terapéutico 2001.
[2]
A López Encuentra.
The Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Criteria of functional and oncological operability in surgery for lung cancer: a multicenter study.
Lung Cancer, 20 (1998), pp. 161-168
[3]
A López Encuentra, Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S).
Comorbidity in lung cancer. A multicenter descriptive study of 2,992 patients.
Lung Cancer, 35 (2002), pp. 263-269
[4]
DH Harpole, MM deCamp, K Hur, et al.
Prognostic models of thirty-day mortality and morbidity after major pulmonary resection.
J Thorac Cardiovasc Surg, 117 (1999), pp. 969-979
[5]
G Varela, J Toledo.
Pulmonary resection for lung cancer in the elderly.
Perioperative care. Currents topics in general thoracic surgery. An international series, pp. 160-163
[6]
M de Perrot, M Licker, MA Reymond, J Robert, A Spiliopoulos.
Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma.
Eur Respir J, 14 (1999), pp. 419-422
[7]
British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party.
Guidelines on the selection of patients with lung cancer for surgery.
Thorax, 56 (2001), pp. 89-108
[8]
R Battafarano, JF Piccirillo, B Meyers, et al.
Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer.
J Thorac Cardiovasc Surg, 123 (2002), pp. 280-287
[9]
JA Wernly, TR DeMeester.
Preoperative assessment of patients undergoing lung resection for cancer.
Thoracic oncology, 2nd ed., pp. 104-124
[10]
E Guadagnoli, A Weitberg, V Mor, RA Silliman, AS Glicksman, FJ Cummings.
The influence of patient age on the diagnosis and treatment of lung and colorectal cancer.
Arch Intern Med, 150 (1990), pp. 1485-1490
[11]
A López Encuentra, J Martínez González del Río, E Pérez Rodríguez.
Datos epidemiológicos en carcinoma broncogénico.
Med Clin (Barc), 72 (1979), pp. 361-368
[12]
Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica (GCCB-S).
La cirugía del carcinoma broncogénico en España. Estudio descriptivo.
Arch Bronconeumol, 31 (1995), pp. 303-309
[13]
JL Aller Álvarez, JF de Frutos Arribas, A Díez Herranz, et al.
Comorbilidad.
El carcinoma broncopulmonar en la Comunidad de Castilla y León. Año 1997, pp. 81-88
[14]
JL Duque, G Ramos, J Castrodeza, J Cerezal, M Castanedo, MG Yuste, et al.
Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica.
Ann Thorac Surg, 63 (1997), pp. 944-950
[15]
H Belzberg, AI Rivkind.
Preoperative cardiac preparation.
Chest, 115 (1999), pp. S82-S95
[16]
SA McClave, HL Snider, DA Spain.
Preoperative issues in clinical nutrition.
Chest, 115 (1999), pp. S64-S70
[17]
H Uramato, R Kakahishi, Y Fujino, et al.
Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer.
Thorax, 56 (2001), pp. 59-61
[18]
JL Duque, Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S).
Mortality after pneumonectomy in patients with lung cancer and know cardiac disease.
Lung Cancer, 29 (2000), pp. 135
[19]
KA Eagle, PB Berger, H Calkins, BR Chaitman, GA Ewy, KE Fleischmann, et al.
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
Circulation, 105 (2002), pp. 1257-1267
[20]
LF Pastor Torres, R Antiago Ramírez, JM Honorato Pérez, CM Junquera Planas, E Navarro Salas, FJ Ortiguera Aso, et al.
Guías de práctica clínica de la Sociedad Española de Cardiología en la valoración del riesgo quirúrgico del paciente cardiópata sometido a cirugía no cardíaca.
Rev Esp Cardiol, 54 (2001), pp. 186-193
[21]
R Hubbard, A Venn, S Lewis, J Britton.
Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
Am J Respir Crit Care Med, 161 (2000), pp. 5-8
[22]
DM Skillrud, KP Offord, RD Miller.
Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.
Ann Intern Med, 105 (1986), pp. 503-507
[23]
K Steenland, W Sanderson.
Lung cancer among industrial sand workers exposed to crystalline silica.
Am J Epidemiol, 153 (2001), pp. 695-703
[24]
Grupo de Trabajo SEPAR.
Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica, Doyma, (2001),
[25]
T Díaz Cambriles, A López Encuentra, JL Martín de Nicólas, L Rey Terrón, MV Valeri Busto, P Martín Escribano.
¿Puede mejorar o no modificarse el FEV1 tras resección pulmonar por carcinoma broncogénico?.
Arch Bronconeumol, 37 (2001), pp. 73-74
[26]
RJ Korst, RJ Ginsberg, M Ailawadi, et al.
Lobectomy improves ventilatory function in selected patients with severe COPD.
Ann Thorac Surg, 66 (1998), pp. 898-902
[27]
A López Encuentra, F Pozo Rodríguez, P Martín Escribano, et al.
Surgical lung cancer. Risk operative analysis.
Lung Cancer, 43 (2004), pp. 361-362
[28]
G Santos-García, G Varela, N Novoa, MF Jiménez.
Prediction of postoperative morbidity after lung resection using an artificial neural network ensemble.
Artif Intell Med, 30 (2004), pp. 61-69
[29]
A Brunelli, A Fianchini, R Gesuita, F Carle.
POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity.
Ann Thorac Surg, 67 (1999), pp. 329-331
[30]
PS Romano, LL Roos, JG Jollis.
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.
J Clin Epidemiol, 46 (1993), pp. 1075-1079
[31]
A Bernard, L Ferrand, O Hagry, L Benoit, N Cheynel, JP Favre.
Identification of prognostic factors determining risk groups for lung resection.
Ann Thorac Surg, 70 (2000), pp. 1161-1167
[32]
TH Lee, ER Marcantonio, CM Mangione, et al.
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Circulation, 100 (1999), pp. 1043-1049
[33]
Locke KA. Clinical prediction guide. A simple index predicted cardiac complications in elective major noncardiac surgery. ACP Journal Club; March-April 2000.
[34]
K Gilbert, BJ Larocque, LT Patrick.
Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery.
Ann Intern Med, 133 (2000), pp. 356-359
[35]
C Mittman.
Assessment of operative risk in thoracic surgery.
Am Rev Respir Dis, 84 (1961), pp. 197-207
[36]
F Nagasaki, BJ Flehinger, N Martini.
Complications of surgery in the treatment of carcinoma of the lung.
Chest, 82 (1982), pp. 25-29
[37]
GN Olsen, AJ Block, EW Swenson, JR Castle, JW Wynne.
Pulmonary function evaluation of the lung resection candidate: a prospective study.
Am Rev Respir Dis, 111 (1975), pp. 379-387
[38]
J Reilly.
Evidence-based preoperative evaluation of candidates for thoracotomy.
Chest, 116 (1999), pp. S474-S476
[39]
American College of Chest Physicians.
Preoperative pulmonary function testing.
Ann Intern Med, 112 (1990), pp. 793-794
[40]
RC Morice, EJ Peters, MB Ryan, JD Putnam, MK Ali, JA Roth.
Exercise testing in the evaluation of patients at high risk for complications from lung resection.
Chest, 101 (1992), pp. 356-361
[41]
CT Bolliger, AP Perruchoud.
Functional evaluation of the lung resection candidate.
Eur Respir J, 11 (1998), pp. 198-212
[42]
DJ Kearney, TH Lee, JJ Reilly, MM deCamp, DJ Sugarbaker.
Assessment of operative risk in patients undergoing lung resection.
Chest, 105 (1994), pp. 753-759
[43]
J Ribas.
Aplicabilidad de las pruebas de esfuerzo en Neumología.
Arch Bronconeumol, 36 (2000), pp. 44-51
[44]
JA Meléndez, ME Fischer.
Preoperative pulmonary evaluation of the thoracic surgical patient.
Chest Surg Clin North Am, 7 (1997), pp. 641-654
[45]
JI Miller.
Physiologic evaluation of pulmonary function in the candidate for lung resection.
J Thorac Cardiovasc Surg, 105 (1993), pp. 347-352
[46]
C Wyser, P Stulz, M Soler, M Tamm, J Muller-Brand, J Habicht, et al.
Prospective evaluation of an algorithm for the functional assessment of lung resection candidates.
Am J Respir Crit Care Med, 159 (1999), pp. 1450-1456
[47]
M Bousamra II, KW Presberg, JH Chammas, JS Tweddell, BL Winton, MR Bielefeld, et al.
Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity.
Ann Thorac Surg, 62 (1996), pp. 968-975
[48]
MK Ferguson, L Little, L Rizzo, et al.
Diffusing capacity predicts morbidity and mortality after pulmonary resection.
J Thorac Cardiovasc Surg, 96 (1988), pp. 894-900
[49]
J Markos, BP Mullan, DR Hillman, AW Musk, VF Antico, FT Lovegrove, et al.
Preoperative assessment as a predictor of mortality and morbidity after lung resection.
Am Rev Respir Dis, 139 (1989), pp. 902-910
[50]
MLR Ladurie, B Ranson-Bitker.
Uncertainties in the expected value for forced expiratory volume in one second after surgery.
Chest, 90 (1986), pp. 222-228
[51]
G Varela, MF Jiménez, N Novoa, JL Aranda.
Concordancia entre el tipo de resección programada y la efectuada en pacientes con carcinoma pulmonar.
Arch Bronconeumol, 41 (2005), pp. 84-87
[52]
PA Corris, DA Ellis, T Hawkins, GJ Gibson.
Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy.
Thorax, 42 (1987), pp. 285-291
[53]
CT Bolliger, P Jordan, M Soler, P Stulz, E Gradel, K Skarvan, et al.
Exercise capacity as a predictor of postoperative complications in lung resection candidates.
Am J Respir Crit Care Med, 151 (1995), pp. 1472-1480
[54]
L Puente-Maestu, JM Ruiz de Ona, JL Rodríguez-Hermosa, SA Santa-Cruz, E Tatay, JM Cubillo.
Predicción de la capacidad de esfuerzo tras la resección pulmonar en pacientes con limitación crónica al flujo aéreo.
Arch Bronconeumol, 34 (1998), pp. 473-478
[55]
RJ Pierce, JM Copland, K Sharpe, CE Barter.
Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality.
Am J Respir Crit Care Med, (1994), pp. 947-955
[56]
CT Bolliger, C Wyser, H Roser, M Soler, AP Perruchoud.
Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications.
Chest, 108 (1995), pp. 341-348
[57]
J Ribas, O Díaz, JA Barberá, M Mateu, E Canalis, L Jover, et al.
Invasive exercise testing in the evaluation of patients at high-risk for lung resection.
Eur Respir J, 12 (1998), pp. 1429-1435
[58]
DA Holden, TW Rice, K Stelmach, DP Meeker.
Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection.
Chest, 102 (1992), pp. 1774-1779
[59]
N Tsubota, M Yanagawa, M Yoshimura, A Murotani, T Hatta.
The superiority of exercise testing over spirometry in the evaluation of postoperative lung function for patients with pulmonary disease.
Surg Today, 24 (1994), pp. 103-105
[60]
GN Olsen, JWR Bolton, DS Weiman, JL Haynes, CA Hornung, CH Almond.
Stair climbing as an exercise test to predict the postoperative complications of lung resection.
Chest, 99 (1991), pp. 587-590
[61]
RK Larsen, UG Svendsen, N Milman, J Brenoe, BN Petersen.
Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma.
Eur Respir J, 10 (1997), pp. 1559-1565
[62]
TP Smith, GT Kinasewitz, WY Tucker, WP Spillers, RB George.
Exercise capacity as predictor of post-thoracotomy morbidity.
Am Rev Respir Dis, 129 (1984), pp. 730-734
[63]
R Torchio, C Gulotta, M Parvis, R Pozzi, R Giardino, P Borasio, et al.
Gas exchange threshold as a predictor of severe postoperative complications after lung resection in mild-to-moderate chronic obstructive pulmonary disease.
Monaldi Arch Chest Dis, 53 (1998), pp. 127-133
[64]
L Puente Maestu, JL Rodríguez Hermosa, JM Ruiz de Ona, A Santa-Cruz Seminiani, P de Lucas Ramos, J García de Pedro, et al.
Papel de la estimación preoperatoria de la captación máxima de oxígeno en la predicción de insuficiencia cardiorrespiratoria en el período postoperatorio inmediato en la cirugía torácica.
Arch Bronconeumol, 34 (1998), pp. 127-132
[65]
NC Colman, DE Schraufnagel, RN Rivington, RL Pardy.
Exercise testing in the evaluation of patients for lung resection.
Ann Thorac Surg, 44 (1987), pp. 344-349
[66]
PG Boysen, CA Clark, AJ Block.
Graded exercise testing and post-thoracotomy complications.
J Cardiothorac Anesth, 4 (1990), pp. 68-72
[67]
CT Bolliger, M Soler, P Stulz, E Gradel, J Muller-Brand, S Elsasser, et al.
Evaluation of high-risk lung resection candidates: pulmonary haemodynamics versus exercise testing. A series of five patients.
Respiration, 61 (1994), pp. 181-186
[68]
P Pate, MF Tenholder, JP Griffin, CE Eastridge, DS Weiman.
Preoperative assessment of the high-risk patient for lung resection.
Ann Thorac Surg, 61 (1996), pp. 1494-1500
[69]
GL Walsh, RC Morice, JB Putnam, JC Nesbitt, MJ McMurtrey, B Ryan, et al.
Resection of lung cancer is justified in high risk patients selected by exercise oxygen consumption.
Ann Thorac Surg, 58 (1994), pp. 704-711
[70]
S Miyoshi, K Nakahara, K Ohno, Y Monden, Y Kawashima.
Exercise tolerance test in lung cancer patients: the relationship between exercise capacity and posthoracotomy hospital mortality.
Ann Thorax Surg, 44 (1987), pp. 487-490
[71]
M Okada, M Okada, N Ishii, C Yamashita, T Sugimoto, K Okada, et al.
Right ventricular ejection fraction in the preoperative risk evaluation of candidates for pulmonary resection.
J Thorac Cardiovasc Surg, 112 (1996), pp. 364-370
[72]
K Nakagawa, K Nakahara, S Miyoshi, Y Kawashima.
Oxygen transport during incremental exercise load as predictor of operative risk in lung cancer patients.
Chest, 101 (1992), pp. 1369-1375
[73]
EA Rendina, T de Giacomo, F Venuta, AM Ciccone, GF Coloni.
Lung conservation techniques: bronchial sleeve resection and reconstruction of the pulmonary artery.
Semin Surg Oncol, 18 (2000), pp. 165-172
[74]
GN Olsen, DS Wiman, JWR Bolton, D Gass, WC McLain, GA Schoonover, et al.
Submaximal invasive exercise testing and quantitative lung scanning in the evaluation of tolerance to lung resection.
Chest, 95 (1989), pp. 267-273
[75]
G Varela, R Cordovilla, MF Jiménez, N Novoa.
Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection.
Eur J Cardiothorac Surg, 19 (2001), pp. 351-354
[76]
V von Dossow, M Welte, U Zaune, E Martin, M Walter, J Ruckert, et al.
Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery.
Anesth Analg, 92 (2001), pp. 848-854
[77]
GI Bardoczky, LL Szegedi, AA d'Hollander, JM Moures, P de Francquen, JC Yernault.
Two-lung and one-lung ventilation in patients with chronic obstructive pulmonary disease: the effects of position and FiO2.
Anesth Analg, 90 (2000), pp. 35-41
[78]
G Varela, E del Barrio, M Jiménez, P García Cosmes, M Criado, JM López Novoa.
Papel del óxido nítrico en la adaptación del lecho vascular pulmonar a la ventilación unilateral durante intervenciones torácicas.
Arch Bronconeumol, 34 (1998), pp. 194-198
[79]
G Mascotto, M Bizzarri, M Messina, E Cerchierini, G Torri, A Carozzo, et al.
Prospective, randomized, controlled evaluation of the preventive effects of positive end-expiratory pressure on patient oxygenation during one-lung ventilation.
Eur J Anaesthesiol, 20 (2003), pp. 704-710
[80]
SR Craig, HA Leaver, PL Yap, GC Pugh, WS Walker.
Acute phase responses following minimal access and conventional thoracic surgery.
Eur J Cardiothorac Surg, 20 (2001), pp. 455-463
[81]
I Nagahiro, A Andou, M Aoe, Y Sano, H Date, N Shimizu.
106. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure.
Ann Thorac Surg, 72 (2001), pp. 362-365
[82]
AP Yim, S Wan, TW Lee, AA Arifi.
VATS lobectomy reduces cytokine responses compared with conventional surgery.
Ann Thorac Surg, 70 (2000), pp. 243-247
[83]
S Kaseda, T Aoki, N Hangai, K Shimizu.
Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy.
Ann Thorac Surg, 70 (2000), pp. 1644-1646
[84]
M Nakata, H Saeki, N Yokoyama, A Kurita, W Takiyama, S Takashima.
Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy.
Ann Thorac Surg, 70 (2000), pp. 938-941
[85]
TJ Kirby, MJ Mack, RJ Landreneau, TW Rice.
Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial.
J Thorac Cardiovasc Surg, 109 (1995), pp. 997-1001
[86]
RJ Landreneau, F Pigula, JD Luketich, RJ Keenan, S Bartley, LS Fetterman, et al.
Acute and chronic morbidity differences between muscle-sparing and standard lateral thoracotomies.
J Thorac Cardiovasc Surg, 112 (1996), pp. 1346-1350
[87]
RA Damhuis, PR Schutte.
Resection rates and postoperative mortality in 7899 patients with lung cancer.
Eur Respir J, 9 (1996), pp. 7-10
[88]
RJ Ginsberg, LV Rubinstein.
The Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer.
Ann Thorac Surg, 60 (1995), pp. 615-622
[89]
Y Sekine, T Iwata, M Chiyo, K Yasufuku, S Motohashi, S Yoshida, et al.
Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease.
Ann Thorac Surg, 76 (2003), pp. 356-362
[90]
RJ Keenan, RJ Landreneau, RH Maley Jr, D Singh, R Macherey, S Bartley, et al.
Segmental resection spares pulmonary function in patients with stage I lung cancer.
Ann Thorac Surg, 78 (2004), pp. 228-233
[91]
M Licker, M de Perrot, L Hohn, JM Tschopp, J Robert, JG Frey, et al.
Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma.
Eur J Cardiothorac Surg, 15 (1999), pp. 314-319
[92]
H Wada, T Nakamura, K Nakamoto, M Maeda, Y Watanabe.
Thirty-day operative mortality for thoracotomy in lung cancer.
J Thorac Cardiovasc Surg, 115 (1998), pp. 70-73
[93]
T Yano, H Yokoyama, Y Fukuyama, E Takai, K Mizutani, Y Ichinose.
The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis.
Eur J Cardiothorac Surg, 11 (1997), pp. 445-449
[94]
RH Breyer, C Zippe, WF Pharr, RJ Jensik, CF Kittle, LP Faber.
Thoracotomy in patients over age seventy years: ten-year experience.
J Thorac Cardiovasc Surg, 81 (1981), pp. 187-193
[95]
W Weiss.
Operative mortality and five-year survival rates in men with bronchogenic carcinoma.
Chest, 66 (1974), pp. 483-487
[96]
R Wahi, MJ McMurtrey, LF deCaro, CF Mountain, MK Ali, TL Smith, et al.
Determinants of perioperative morbidity and mortality after pneumonectomy.
Ann Thorac Surg, 48 (1989), pp. 33-37
[97]
J Klemperer, RJ Ginsberg.
Morbidity and mortality after pneumonectomy.
Chest Surg Clin N Am, 9 (1999), pp. 515-525
[98]
CD Wright, JC Wain, DJ Mathisen, HC Grillo.
Postpneumonectomy bronchopleural fistula after sutured bronchial closure: incidence, risk factors, and management.
J Thorac Cardiovasc Surg, 112 (1996), pp. 1367-1371
[99]
M de Perrot, M Licker, J Robert, A Spiliopoulos.
Incidence, risk factors and management of bronchopleural fistulae after pneumonectomy.
Scand Cardiovasc J, 33 (1999), pp. 171-174
[100]
A Jalal, K Jeyasingham.
Bronchoplasty for malignant and benign conditions: a retrospective study of 44 cases.
Eur J Cardiothorac Surg, 17 (2000), pp. 370-376
[101]
M Kruger, K Uschinsky, K Hassler, C Engelmann.
Postoperative complications after bronchoplastic procedures in the treatment of bronchial malignancies.
Eur J Cardiothorac Surg, 14 (1998), pp. 46-52
[102]
HC Suen, BF Meyers, T Guthrie, MS Pohl, S Sundaresan, CL Roper, et al.
Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies.
Ann Thorac Surg, 67 (1999), pp. 1557-1562
[103]
I Yoshino, H Yokoyama, T Yano, T Ueda, E Takai, K Mizutani, et al.
Comparison of the surgical results of lobectomy with bronchoplasty and pneumonectomy for lung cancer.
J Surg' Oncol, 64 (1997), pp. 32-35
[104]
M Tedder, MP Anstadt, SD Tedder, JE Lowe.
Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy.
Ann Thorac Surg, 54 (1992), pp. 387-391
[105]
K Kodama, M Higashiyama, H Yokouchi, K Takami, T Yasuda, T Kabuto.
Survival and postoperative complications after extended surgery for non-small-cell lung cancer. A retrospective study.
Jpn J Thorac Cardiovasc Surg, 47 (1999), pp. 546-551
[106]
PC Pairolero, VF Trastek, WS Payne.
Treatment of bronchogenic carcinoma with chest wall invasion.
Surg Clin North Am, 67 (1987), pp. 959-964
[107]
E Busch, G Verazin, JG Antkowiak, D Driscoll, H Takita.
Pulmonary complications in patients undergoing thoracotomy for lung carcinoma.
Chest, 105 (1994), pp. 760-766
[108]
CCW Hsia, RM Peshock, AS Estrera, DD McIntire, M Ramanathan.
Respiratory muscle limitation in patients after pneumonectomy.
Am Rev Respir Dis, 147 (1993), pp. 744-752
[109]
H Maeda, K Nakahara, K Ohno, T Kido, M Ikeda, Y Kawashima.
Diaphragm function after pulmonary resection: relationship to postoperative respiratory failure.
Am Rev Respir Dis, 137 (1988), pp. 678-681
[110]
JG Jones, DJ Sapsford, RG Wheatley.
Postoperative hypoxaemia: mechanisms and time course.
Anaesthesia, 45 (1990), pp. 566-573
[111]
H Nomori, H Horio, G Fuyuno, R Kobayashi, H Yashima.
Respiratory muscle strength after lung resection with special reference to age and procedures of thoracotomy.
Eur J Cardiothorac Surg, 10 (1996), pp. 352-358
[112]
WD Watkins, PD Lumb.
pp. 6
[113]
CP Aldren, LC Barr, RD Leach.
Hypoxaemia and postoperative pulmonary complications.
Br J Surg, 78 (1991), pp. 1307-1308
[114]
MD Entwistle, PG Roe, DJ Sapsford, RG Berrisford, JG Jones.
Patterns of oxygenation after thoracotomy.
Br J Anaesthesia, 67 (1991), pp. 704-711
[115]
TJ Overend, CM Anderson, SD Lucy, C Bhatia, BI Jonsson, C Timmermans.
The effect of incentive spirometry on postoperative pulmonary complications: a systematic review.
Chest, 120 (2001), pp. 971-978
[116]
P Weiner, A Man, M Weiner, M Rabner, J Waizman, R Magadle, et al.
The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection.
J Thorac Cardiovasc Surg, 113 (1997), pp. 552-557
[117]
JL Duque Medina.
Edema pulmonar postneumonectomía.
Complicaciones en cirugía torácica, pp. 17-22
[118]
D Duogenis, V Patrinou, KS Filos, et al.
Blood use in lung resection for carcinoma: perioperative elective anaemia does not compromise the early outcome.
Eur J Cardiothorac Surg, 20 (2001), pp. 372-377
[119]
L Stehling, NLC Luban, KC Anderson, et al.
Guidelines for blood utilization review.
Transfusion, 34 (1994), pp. 438-448
[120]
P Hebert, G Wells, MA Blajchman, et al.
Canadian critical care trials group. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care.
N Engl J Med, 340 (1999), pp. 409-417
[122]
BG Covino.
Interpleural regional anesthesia [editorial].
Anesth Analg, 67 (1987), pp. 427-429
[123]
TK Aldrich, DJ Prezant.
Adverse effects of drugs on the respiratory muscles.
Clinics in Chest Medicine, 11 (1990), pp. 177-189
[124]
RJ Ginsberg.
Multimodality therapy for stage III N2 lung cancer. An overview.
Chest, 103 (1993), pp. 356S-359S
[125]
C Doddoli, P Thomas, X Thirion, et al.
Postoperative complications in relation with induction therapy for lung cancer.
Eur J Cardiothorac Surg, 20 (2001), pp. 385-390
[126]
N Novoa, G Varela, MF Jiménez.
Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy.
Eur J Cardiothorac Surg, 20 (2001), pp. 700-704
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
